Healthcare · Biotechnology · NASDAQ

Vertex Pharmaceuticals Inc (VRTX) Stock Price, Analysis & Trade Signals

$533.96-3.83 (-0.71%)

Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductance regulator gene. Additionally, they provide TRIKAFTA for individuals with CF aged six years and older who possess at least one F508del mutation. Beyond its established CF therapies, Vertex maintains a…

VRTX key stats

Market Cap
$135.38B
P/E Ratio
34.61
Forward P/E
26.18
EPS
15.54
52 Week Range
$0.00 – $568.67
50-Day Avg
522.20
200-Day Avg
483.68
Revenue (TTM)
$12.95B
Revenue Growth (Qtr YoY)
11.8%
Profit Margin
31%
Operating Margin (TTM)
37.8%
Beta
0.28
Volume
639.22K
30-Day Avg Volume
1.53M
Next Earnings
Feb 11, 2027
Estimated EPS
4.2
CEO
Reshma Kewalramani
Employees
6,400
IPO Date
Jul 24, 1991

VRTX on X: what traders are saying

  • Marty Chargin @MartyChargin · Nov 11, 2026

    @daveglass1 $LLY $VRTX $CAH $MCK $ABBV ... Yo Dave ... that looks good to me... you got it covered form many angles.....

  • WOLF @WOLF_Financial · Nov 2, 2026

    HERE ARE THE COMPANIES REPORTING EARNINGS AFTER THE BELL TODAY Including Apple and Palantir Apple $AAPL • EPS: $1.98 est • Revenue: $112.95B est Palantir $PLTR • EPS: $0.40 est • Revenue: $2.17B est Vertex Pharmaceuticals $VRTX • EPS: $4.92 est • Revenue: $3.40B est…

  • WOLF @WOLF_Financial · Oct 30, 2026

    HERE'S WHAT THE ?? STOCK MARKET LOOKS LIKE SO FAR TODAY ??? Up • Regeneron $REGN +11.5% • T-Mobile $TMUS +6.6% • Accenture $ACN +4.5% • Mondelez $MDLZ +4.0% • Intercontinental Exchange $ICE +3.8% • Republic Services $RSG +3.8% • Vertex Pharmaceuticals $VRTX +3.8% •…

  • Paul R. La Monica @LaMonicaBuzz · Oct 30, 2026

    Red all around as the sell-off accelerates. But amazingly enough, there are some stocks out there hitting new all-time highs. $XOM $CVX $SHEL $COP $LNG $PR $GILD $JNJ $ABBV $LLY $VRTX $AMGN $V $MA $ED $CB $CAH $PM $BRK.B to name a few.

  • Paul R. La Monica @LaMonicaBuzz · Oct 30, 2026

    Earnings galore too. $AAPL $PLTR $VRTX $MAR $ON $FOXA $ROKU $AMD $AMGN $SHOP $PFE $ETN $BKNG $RACE $APO $KDP $XYZ $YUM $SYY $ARM $QCOM $NVO $MCD $UBER $CVS $MCK $DDOG $APP $ALL $MET $AFL $CRCL Barron's/Dow Jones owner $NWSA $COP $SONY $MNST $ABNB $LITE $MRNA $HUM $VST + many more

  • Marty Chargin @MartyChargin · Oct 30, 2026

    $VRTX ... The drugs are working....stocks that is.... I hope it does not wear off soon... Vertex reports earnings on Monday https://t.co/2PZ3UDKQtz

VRTX analyst rating & price target

29 analysts rate VRTX Buy on consensus.

4Strong Buy
19Buy
4Hold
1Sell
1Strong Sell

Consensus price target: $571.39 (+7.01% upside from $533.96)

Recent VRTX insider transactions

InsiderDateTransactionSharesValue
Bozic Carmen
EVP and CMO
Jun 15, 2026Sale4,062$1.83M
Bozic Carmen
EVP and CMO
May 12, 2026Sale6,988$3.14M
Liu Joy
EVP and Chief Legal Officer
Apr 1, 2026Sale978$439.29K
McKechnie Duncan
EVP, Chief Commercial Officer
Mar 11, 2026Sale2,633$1.31M
McKechnie Duncan
EVP, Chief Commercial Officer
Mar 4, 2026Sale2,437$1.16M

Vertex Pharmaceuticals Inc annual revenue & net income

Fiscal yearRevenueRevenue YoYNet income
2025$12.07B+9.57%$3.95B
2024$11.02B+11.66%$-535.6M
2023$9.87B+10.51%$3.62B

Latest VRTX news

Stock data for VRTX: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics